Supplementary Materials and Methods

Plasmid construction
The following constructs were previously described: pCMV-Myc-PNRC2 (16), pc-6bs (32), phCMV-MUP (47), pCMV-Myc-Upf1 R (29), pCMV-Myc-Upf1(G495R/G497E) (48), pcDNA3-FLAG (6,16), pcDNA3-FLAG-Dcp1a (39), pcDNA3-FLAG-Dcp2 (39), pmCMVGl-norm (49), pmCMV-Gl-Ter (49), pmCMV-GPx1-norm (50), pmCMV-GPx1-Ter (50), pMS2-HA (29), and pMS2-HA-PNRC2 (16).
To construct pcDNA3-FLAG-SMG5, a Klenow-filled BamHI/HindIII fragment of pcDNA3-FLAG (6,16) was ligated to two fragments: (i) a Klenow-filled XhoI/KpnI fragment that encoded the N-terminal region of SMG5 and (ii) a PCR-amplified KpnI/HindIII fragment that encoded the C-terminal region of SMG5, which was amplified using pEYFP-N1-SMG5
(19) and two oligonucleotides: 5'-GTGATCGATGGCCTGGATTTGCTGAAG-3' (sense) and 5'-TCCCCGCGGAAGCTTCAACCAATTTCCTTCCACTGCTTGTAGAAG-3' (antisense),
where the underlined nucleotides specify HindIII sites.
To construct pcDNA3-FLAG-SMG6, a Klenow-filled BamHI/KpnI fragment of pcDNA3-FLAG was ligated to two fragments: (i) a Klenow-filled XbaI/XhoI fragment that encoded the N-terminal region of SMG6 and (ii) a PCR-amplified XhoI/KpnI fragment that encoded the C-terminal region of SMG6, which was amplified using pcDNA3-HA-SMG6 R (17) and two oligonucleotides: 5'-CAAGAGAAGGCCCGCAAGTCCATCGAG-3'(sense) and 5'-GGGGTACCTCAGCCCACCTGGGCCCACGTGAGGAA-3' (antisense), where the underlined nucleotides specify the KpnI sites.
To construct pcDNA3-FLAG-SMG7, a Klenow-filled BamHI/KpnI fragment of pcDNA3-FLAG was ligated to two fragments: (i) a Klenow-filled XhoI/BglII fragment that encoded the N-terminal region of SMG7 and (ii) a PCR-amplified BglII/KpnI fragment that encoded the C-terminal region of SMG7, which was amplified using pEYFP-N1-SMG7 (19) 3 and two oligonucleotides: 5'-GAATTCTACTGGGATTCTTCCTACAGC-3' (Sense) and 5'-GGGGTACCTCAGTGTGGAGGGTTCATGGTGCCTTGTCC-3' (Antisense), where the underlined nucleotides specify KpnI sites.
pMS2-HA-SMG5, SMG6, and SMG7, which encode an N-terminal oligomerizationdefective MS2 coat protein followed by a HA tag and full-length human SMG5, SMG6, and SMG7 cDNA, respectively, were generated in two steps. First, the plasmids expressing HA-SMG5, HA-SMG6, and HA-SMG7 were constructed. Second, the HA-tagged SMG5/6/7 fragments were inserted downstream of the MS2 cDNA. The details of this process are described below.
To construct pCMV-HA-SMG5, pCMV-HA (16) was digested with EcoRI and SacII and was ligated to two fragments: (i) a EcoRI/KpnI fragment that encoded an N-terminal region of SMG5 and (ii) a PCR-amplified KpnI/SacII fragment that encoded the C-terminal region of SMG5, which was amplified using pEYFP-N1-SMG5 and two oligonucleotides: 5'-GTGATCGATGGCCTGGATTTGCTGAAG-3' (sense) and 5'-
where the underlined nucleotides specify SacII sites.
To construct pCMV-HA-SMG6, a XbaI/KpnI fragment of pCMV-HA was ligated to two fragments: (i) a XbaI/XhoI fragment that encoded an N-terminal region of SMG6 and (ii) a PCR-amplified XhoI/KpnI fragment that encoded the C-terminal region of SMG6, which was amplified using pcDNA3-HA-SMG6 R with two oligonucleotides: 5'-CAAGAGAAGGCCCGCAAGTCCATCGAG-3'(sense) and 5'-GGGGTACCTCAGCCCACCTGGGCCCACGTGAGGAA-3' (antisense), where the underlined nucleotides specify the KpnI sites.
To construct pCMV-HA-SMG7, pCMV-HA, which was treated with PstI, T4 DNA polymerase and KpnI was ligated to two fragments: (i) a Klenow-filled XhoI/BglII fragment that encoded an N-terminal region of SMG7 and (ii) a PCR-amplified BglII/KpnI fragment that encoded the C-terminal region of SMG7, which was amplified using pEYFP-N1-SMG7 with two oligonucleotides: 5'-GAATTCTACTGGGATTCTTCCTACAGC-3' (sense) and 5'-GGGGTACCTCAGTGTGGAGGGTTCATGGTGCCTTGTCC-3' (antisense), where the underlined nucleotides specify KpnI sites. The resulting plasmid was re-digested with XhoI and treated with Klenow. The fragment was then self-ligated.
To construct pMS2-HA-SMG5, pMS2-HA-PNRC2 digested with XhoI and NotI was ligated to two fragments: (i) a XhoI/KpnI fragment of pcDNA3-FLAG-SMG5 and (ii) a KpnI/NotI fragment of pCMV-HA-SMG5.
To construct pMS2-HA-SMG6, pMS2-HA-PNRC2 digested with XhoI and NotI was ligated to two fragments: (i) a XhoI/HindIII fragment of pcDNA3-HA-SMG6 R and (ii) a HindIII/NotI fragment of pCMV-HA-SMG6.
To construct pMS2-HA-SMG7, a Klenow-filled Xho/NotI fragment of pMS2-HA-PNRC2 was ligated to two fragments: (i) a Klenow-filled EcoRI/XbaI fragment of pCMV-HA-SMG7 and (ii) a XbaI/NotI fragment of pCMV-HA-SMG7.
To construct pMS2-HA-Upf1, a Klenow-filled XhoI/NotI fragment of pMS2-HA-PNRC2 was ligated to a Klenow-filled NotI fragment of pcDNA3-FLAG-Upf1 (16).
pcDNA3-FLAG-Hedls, pcDNA3-FLAG-EDC3, and pcDNA3-FLAG-Rck/p54 were constructed by inserting a Klenow-filled EcoRI/NotI fragment from pcDNA3-Myc-Hedls (39), a Klenow-filled HindIII/NotI fragment from pcDNA3-Myc-EDC3 (39), and a Klenowfilled HindIII/NotI fragment from pcDNA3-Myc-HA-Rck/p54 (39), respectively, into a Klenow-filled BamHI site of pcDNA3-FLAG.
To generate plasmid pCMV-Myc-Upf1 R (T28A), the fragment harboring human Upf1 (T28A) cDNA was obtained by two-step PCRs. At first, 5'-and 3'-fragments of Upf1 were amplified by PCR using pCMV-Myc-Upf1 R (29) as a template and the specific oligonucleotides: (i) 5'-GCTGCGGAATTGTACCCGCGGGCCCACC-3' (sense) and 5'-CTCGGAGCCCTGTGCGTCGGCGCCAAGCAG-3' (antisense) for the amplification of the 5'-fragment, and (ii) 5'-CTGCTTGGCGCCGACGCACAGGGCTCCGAG-3' (sense) and 5'-CTCTGCGGTGCGCTTCAAGGCCCGGTAC-3' (antisense) for the amplification of the 3'-fragment, where italicized nucleotides specify the mutations that introduce T28A. Next, second PCR was performed using two PCR-amplified fragments and two oligonucleotides:
the sense oligonucleotide used for the amplification of the 5'-fragment and the antisense oligonucleotide used for the amplification of the 3'-fragment. Finally, a PCR-amplified fragment of human Upf1 (T28A) cDNA was digested with EcoRI/KpnI and then ligated to the EcoRI/KpnI fragment of pCMV-Myc-Upf1 R .
Quantitative real-time PCR and RT-PCR using -[ 32 P]-dATP
Quantitative real-time PCR (qRT-PCR) analyses were performed using the LightCycler™ system (Roche Diagnostics). qRT-PCR was performed with single-stranded cDNA and genespecific oligonucleotides using the Lightcycler 480 SYBR Green I Master (Roche Diagnostics). Lightcycler PCR conditions were initial denaturation for 10 min at 95°C, followed by 35-45 cycles of 95°C denaturation for 10 s, 57°C annealing for 10 s, and 72°C elongation for 30 s. The expression levels of mRNAs are the means of three independent experiments. Melting curves of the PCR products were performed for quality control. GPx1, -6bs, and MUP mRNAs were amplified using Lightcycler 480 SYBR Green I Master and two specific oligonucleotides (Supplementary Table S4 ). When Gl and MUP mRNAs were amplified together, Lightcycler 480 Probe Master and gene-specific TaqMan probes were used (Supplementary Table S4 ).
RT-PCR was performed with cDNA and specific glyceraldehyde 3-phosphate dehydrogenase (GAPDH) oligonucleotides (Table S3) in the presence of -[6 (PerkinElmer NEN). Labeled PCR products were analyzed by 5% polyacrylamide gel, visualized by PhosphorImaging (BAS-2500; Fuji Photo Film), as previously described (6, 9, 16, 29) .
Data analyses
To obtain sequence information on the exon-intron boundary, 3'UTR, coding sequences (CDS), and 5'UTR, the GenBank flatfiles corresponding to human RefSeq sequences were downloaded from the NCBI ftp site system. To predict genes harboring PTCs, the distance was measured between the exon-exon junction and the stop codon. Genes with exon-exon junctions more than 50 nts downstream of a stop codon were considered NMD substrates. All the parsing work was performed using a home-built perl scripts.
Statistical analysis
From the microarray datasets produced by SMG5, SMG7, PNRC2, and Upf1 downregulation, commonly differentially expressed genes (DEG) between SMG5 and Upf1 (SMG5&Upf1), between SMG7 and Upf1 (SMG7&Upf1), and between PNRC2 and Upf1 (PNRC2&Upf1) were selected by the arbitrary fold-change cutoffs, 1.5 and 2.0, generating different foldchange datasets. Correlation coefficients for the commonly upregulated genes were then estimated between SMG5&Upf1 and SMG7&Upf1, between SMG5&Upf1 and PNRC2&Upf1, and between SMG7&Upf1 and PNRC2&Upf1 using Kendall's rank correlation test. Supplementary Table S1 . Transcripts upregulated or downregulated by at least 1.5-fold upon downregulation of Upf1, SMG5, SMG7, or PNRC2. Transcripts upregulated or downregulated by at least 2-fold are highlighted in yellow. 
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